Drug reexposure in children with severe mucocutaneous reactions

Allergol Immunopathol (Madr). 2022 Jan 1;50(1):104-107. doi: 10.15586/aei.v50i1.382. eCollection 2022.

Abstract

In pediatric patients, severe cutaneous adverse reactions (SCARs) frequently occur in the course of acute illnesses, mostly infections, which are usually treated with antibiotics or analgesics. The drug provocation test (DPT) is contraindicated in such situations, due to the risk of triggering a new severe reaction. As a consequence, lifelong avoidance is recommended. However, causation is uncertain in most cases. The dilemma arises when avoiding the drug is not harmless for the patient. We have attended three patients who were referred to our pediatric allergy unit with a history of SCAR related in time to simultaneous use of paracetamol and ibuprofen. Medical records and images of the patients were reviewed with the assistance of a dermatologist, and alternative diagnoses were considered in both cases. The ALDEN score for implicated drugs was calculated. After considering a high probability of ibuprofen tolerance and obtaining informed consent from the patients, we performed a sequential allergy workup including in vitro tests, skin tests, and finally DPT in two of the patients, confirming ibuprofen tolerance. In conclusion, although generally contraindicated, DPT may be considered for some useful drugs after careful evaluation of the risk-benefit balance, preceded by a sequential study including in vitro and skin tests.

Keywords: Allergy Workup; Children; Drug Provocation Test; Nonsteroidal Anti-inflammatory Drugs; Severe Cutaneous Adverse Reaction.

MeSH terms

  • Anti-Bacterial Agents
  • Child
  • Drug Hypersensitivity* / diagnosis
  • Drug Hypersensitivity* / therapy
  • Humans
  • Ibuprofen / adverse effects
  • Pharmaceutical Preparations*
  • Skin Tests

Substances

  • Anti-Bacterial Agents
  • Pharmaceutical Preparations
  • Ibuprofen